Citations 1
Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations
Martín, Miguel , Esteva, Francisco J. , Alba, Emilio , Khandheria, Bijoy K. , Pérez-Isla, Leopoldo, García-Sáenz, José Á. , Márquez, Antonia, Sengupta, Partho P. , Zamorano, José Luis , Isla, Leopoldo Pérez de , García-Sáenz, José A , Martin, Miguel , Alba, Emilio
The Oncologist | January 16, 2009 | Volume: 14 | Issue: 1 | Pages: 1-11
10.1634/theoncologist.2008-0137
Learning Objectives Analyze the clinical trial data for the treatment of breast cancer. Evaluate the risk of cardiotoxicity associated with the use of trastuzumab. Design and conduct a practical approach to managing patients with trastuzumab-associated cardiotoxicity. This article is available for continuing medical education credit at CME.TheOncologist.com.